About Danny Incarnato
Danny Incarnato, CSO and PhD in molecular biotechnologies, is renowned for his pioneering work in RNA structure and computational biology.
Known information
Danny Incarnato serves as the Chief Scientific Officer (CSO) and holds a PhD in molecular biotechnologies from the University of Siena. He is an expert in RNA structure and computational biology, currently leading research in this field at the University of Groningen. His significant contributions include the development of innovative experimental and computational tools for RNA structure analysis, which have gained widespread adoption in both academic and industrial settings. Notably, his laboratory was the first to solve the structure of the SARS-CoV-2 RNA genome in living infected host cells during the early stages of the COVID-19 pandemic.
About Serna Bio
Serna Bio, formerly Ladder Therapeutics (LTX), is a biotech company specializing in the development of novel therapeutics targeting the transcriptome for diseases with high unmet medical needs.